Current and emerging biologics for the treatment of juvenile idiopathic arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and emerging biologics for the treatment of juvenile idiopathic arthritis

Published:2020-03-02 Issue:7 Volume:20 Page:725-740
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Cimaz Rolando¹²,Maioli Gabriella³,Calabrese Giulia³

Affiliation:

1. Pediatric Rheumatology Department, ASST-Gaetano Pini-CTO, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

2. Pediatric Rheumatology Department, ASST-Gaetano Pini-CTO, University of Milan, Milan, Italy

3. University of Milan, Milan, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1733524

Reference134 articles.

1. It is time to rethink juvenile idiopathic arthritis classification and nomenclature

2. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

3. Leflunomide or Methotrexate for Juvenile Rheumatoid Arthritis

4. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the EQ-5D-Y-5L parent-proxy version among children with juvenile idiopathic arthritis;Quality of Life Research;2024-08-14

2. Extraarticular manifestations of juvenile idiopathic arthritis and their impact on health-related quality of life;Clinical Rheumatology;2024-05-26

3. Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis—an explorative cross-sectional study;Pediatric Rheumatology;2024-03-09

4. Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases;European Journal of Pharmaceutical Sciences;2024-01

5. T lymphocytes-related cell network in the pathogenesis of juvenile idiopathic arthritis: a key point for personalized treatment;Current Opinion in Rheumatology;2023-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3